Objectives Neutrophil to lymphocyte ratio; as an inexpensive, easily measurable, and repeatable laboratory parameter is an indicator of subclinical inflammation, and is also a parameter that gives an idea about the systemic inflammatory response and cellular immune response. In general, lymphopenia reflects the weakness of cellular immunity, while neutrophilia is indicative of the response to systemic inflammation. The ratio of these two values to each other seems to be a marker showing the adequacy of the cellular immune response against this situation, despite the magnitude of systemic inflammation. In this study, we aimed to investigate the relationship between preoperative neutrophil-lymphocyte ratio (NLR) and postoperative analgesic drug consumption. Materials and Method Within the scope of the study, the files of 50 patients who underwent bimaxillary orthognathic surgery were retrospectively analyzed. The preoperative NLR values of the patients and the need for the analgesic drugs in the first 24 hours and after 24 hours were recorded and correlated. Results 24% of the patients were girls and 76% were boys. The average age was 20.54, and the average weight was 65.28 kg. There was a positive, strong, and significant correlation between the preoperative neutrophil count and preoperative NLR value and variables of analgesic drug consumption in the first 24 hours (r = 0.6814, p <0.001, and r = 0.6148, p <0.001, respectively). There was a negative, strong and significant correlation between the preoperative lymphocyte count and the first 24-hour analgesic drug consumption variables (r = -0.6773, p <0.001). Conclusion It was concluded that patients with a preoperative NLR value of 2.11 and above may require 4 or more analgesics in the first 24 hours, therefore, NLR value can give preliminary information about the need for postoperative analgesia, and these values could be taken into account when developing a strategy for postoperative analgesia.
|Konular||Sağlık Bilimleri ve Hizmetleri|
|Bölüm||Original Research Articles|
|Yayımlanma Tarihi||25 Mart 2022|
|Başvuru Tarihi||1 Aralık 2021|
|Kabul Tarihi||16 Şubat 2022|
|Yayınlandığı Sayı||Yıl 2022, Cilt 25, Sayı Supplement|
|EndNote||%0 Cumhuriyet Dental Journal INVESTIGATION OF THE RELATIONSHIP BETWEEN NEUTROPHIL/LYMPHOCYTE RATIO AND ANALGESIC CONSUMPTION IN BIMAXILLARY ORTHOGNATHIC SURGERY PATIENTS %A Seher Orbay Yaşlı , Dilek Günay Canpolat %T INVESTIGATION OF THE RELATIONSHIP BETWEEN NEUTROPHIL/LYMPHOCYTE RATIO AND ANALGESIC CONSUMPTION IN BIMAXILLARY ORTHOGNATHIC SURGERY PATIENTS %D 2022 %J Cumhuriyet Dental Journal %P 1302-5805-2146-2852 %V 25 %N Supplement %R doi: 10.7126/cumudj.1031144 %U 10.7126/cumudj.1031144|
Cumhuriyet Dental Journal (Cumhuriyet Dent J, CDJ) is the official publication of Cumhuriyet University Faculty of Dentistry. CDJ is an international journal dedicated to the latest advancement of dentistry. The aim of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of dentistry. First issue of the Journal of Cumhuriyet University Faculty of Dentistry was published in 1998. In 2010, journal's name was changed as Cumhuriyet Dental Journal. Journal’s publication language is English.
CDJ accepts articles in English. Submitting a paper to CDJ is free of charges. In addition, CDJ has not have article processing charges.
Frequency: Four times a year (March, June, September, and December)
All users of Cumhuriyet Dental Journal should visit to their user's home page through the "https://dergipark.org.tr/tr/user" " or "https://dergipark.org.tr/en/user" links to update their incomplete information shown in blue or yellow warnings and update their e-mail addresses and information to the DergiPark system. Otherwise, the e-mails from the journal will not be seen or fall into the SPAM folder. Please fill in all missing part in the relevant field.
Please visit journal's AUTHOR GUIDELINE to see revised policy and submission rules to be held since 2020.